AU7086787A - Combination of aromatase inhibitors and 5alpha-reductase inhibitors - Google Patents

Combination of aromatase inhibitors and 5alpha-reductase inhibitors

Info

Publication number
AU7086787A
AU7086787A AU70867/87A AU7086787A AU7086787A AU 7086787 A AU7086787 A AU 7086787A AU 70867/87 A AU70867/87 A AU 70867/87A AU 7086787 A AU7086787 A AU 7086787A AU 7086787 A AU7086787 A AU 7086787A
Authority
AU
Australia
Prior art keywords
inhibitors
5alpha
combination
aromatase
reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70867/87A
Other languages
English (en)
Inventor
M. Fathy El Etreby
Ursula-F. Habenicht
Helmut Schroder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU7086787A publication Critical patent/AU7086787A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU70867/87A 1986-03-06 1987-03-03 Combination of aromatase inhibitors and 5alpha-reductase inhibitors Abandoned AU7086787A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3607651 1986-03-06
DE19863607651 DE3607651A1 (de) 1986-03-06 1986-03-06 Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer

Publications (1)

Publication Number Publication Date
AU7086787A true AU7086787A (en) 1987-09-28

Family

ID=6295819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70867/87A Abandoned AU7086787A (en) 1986-03-06 1987-03-03 Combination of aromatase inhibitors and 5alpha-reductase inhibitors

Country Status (4)

Country Link
EP (1) EP0296160A1 (de)
AU (1) AU7086787A (de)
DE (1) DE3607651A1 (de)
WO (1) WO1987005216A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643445B2 (en) * 1989-07-07 1993-11-18 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595985A (en) * 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
KR920703065A (ko) * 1989-07-07 1992-12-17 원본미기재 안드로겐 관련질병의 치료방법
NZ241979A (en) * 1991-03-20 1996-01-26 Merck & Co Inc Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker
AU1893492A (en) * 1991-04-17 1992-11-17 Merck & Co., Inc. Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
RU2141967C1 (ru) * 1992-05-21 1999-11-27 Андорешерш Инк. ИНГИБИТОРЫ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИНГИБИРОВАНИЯ АКТИВНОСТИ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
GB9717428D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
DE2817157A1 (de) * 1978-04-17 1979-10-25 Schering Ag Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
DE3121152A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643445B2 (en) * 1989-07-07 1993-11-18 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia

Also Published As

Publication number Publication date
DE3607651A1 (de) 1987-09-10
WO1987005216A1 (en) 1987-09-11
EP0296160A1 (de) 1988-12-28

Similar Documents

Publication Publication Date Title
AU580164B2 (en) New pest-combating agents and compounds
AU4952885A (en) Lipsomes and compositions of sterol derivatives
AU586684B2 (en) Alfuzosine compositions and use
AU5947886A (en) Tablet package and method of use
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
HUT48824A (en) Transdermal and dermal plaster having several parts
AU6734987A (en) Treatment of emulsions
AU585662B2 (en) Settable compositions and methods of use thereof
AU5730286A (en) Treatment of factor viii inhibitors
AU5289686A (en) Compositions and methods for retarding the effects of aging of the skin
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU6530286A (en) Dementia-improving and therapeutic agents
EP0230596A3 (en) Synergistic herbicide combinations and method of application
AU7086787A (en) Combination of aromatase inhibitors and 5alpha-reductase inhibitors
AU2219588A (en) 5-pyrimidinecarboxamides and treatment of leukemia therewith
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
AU5606586A (en) Pseudopterosin and derivatives
AU576717B2 (en) N6 - bicycloadenosines and methods of use
AU6041786A (en) Preserve of radish and process for preparation thereof
ZA859770B (en) Synergistic combination of flupirtin and 4-acetamido-phenol
AU6697086A (en) Immunoamplifiers and related compositions
GB2187191B (en) Protection of proteins and the like
AU6630086A (en) Transdermal application of nicotine
AU574852B2 (en) 13 - acyloxy - 5 - ketomilbemycin derivatives and preparation of 13 - hydroxy - 5 - ketomilbemycin derivatives
AU6676886A (en) Fluoroalkyltriazoles and diazoles